Prelude Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.91

+0.04 (+0.90%)

As of Sep 28, 10:21 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +140.9% upside

Low Target $6.99

Average Target $9.42

High Target $10.52

Current Price $3.91

Current
$3.91

Target
$9.42

$6.99 $9.42 avg $10.52

Scenario Analysis

Bear Case

$6.99

78.8%

Low target

Base Case

$9.42

+140.9%

Avg target

Bull Case

$10.52

+169.1%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$6.83

-42.8% from high

52-Week Low

$1.04

+276.0% from low

Target vs 52W High

$9.42

+37.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%